Volume 46, Issue 1 pp. 89-91
Case Report

Rescue PTCA complicated by pulmonary artery rupture after tPA and abciximab

Hal L. Chadow MD

Corresponding Author

Hal L. Chadow MD

Department of Medicine, Division of Cardiology, Brookdale University Hospital and Medical Center, Brooklyn, New York

State University of New York Health Science Center, Brooklyn, New York

Cardiac Catheterization Laboratory, State University of New York Health Science Center, 450 Clarkson Avenue, Box 1199, Brooklyn, New York 11203.Search for more papers by this author
Mahender K. Gaba MD

Mahender K. Gaba MD

Department of Medicine, Division of Cardiology, Brookdale University Hospital and Medical Center, Brooklyn, New York

State University of New York Health Science Center, Brooklyn, New York

Search for more papers by this author
Arshad Safi MD

Arshad Safi MD

Department of Medicine, Division of Cardiology, Brookdale University Hospital and Medical Center, Brooklyn, New York

State University of New York Health Science Center, Brooklyn, New York

Search for more papers by this author
Ernest Afflu MD

Ernest Afflu MD

Department of Medicine, Division of Cardiology, Brookdale University Hospital and Medical Center, Brooklyn, New York

State University of New York Health Science Center, Brooklyn, New York

Search for more papers by this author
Alan Feit MD

Alan Feit MD

Department of Medicine, Division of Cardiology, Brookdale University Hospital and Medical Center, Brooklyn, New York

State University of New York Health Science Center, Brooklyn, New York

Search for more papers by this author

Abstract

Since the introduction of pulmonary artery catheterization for hemodynamic monitoring, several complications associated with its use have been described. Pulmonary artery rupture is an infrequent complication of flow-directed pulmonary artery catheters. We report a case of pulmonary artery rupture complicating rescue PTCA in the presence of systemic platelet inhibition with abciximab (Reopro), anticoagulation, and thrombolytic therapy. With the increasing use of these medications in patients undergoing acute coronary interventions, particularly those patients requiring hemodynamic monitoring, this uncommon but potentially fatal complication may be seen more frequently. Cathet. Cardiovasc. Intervent. 46:89–91, 1999. © 1999 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.